Access Bio, Inc. (KOSDAQ:950130)
South Korea · Delayed Price · Currency is KRW 5,290.00
-40.00 (-0.75%)
Aug 14, 2025, 2:39 PM KST
BM Technologies Market Cap
Access Bio has a market cap or net worth of 185.01 billion as of August 14, 2025. Its market cap has decreased by -15.56% in one year.
Market Cap
185.01B
Enterprise Value
-189.95B
Revenue
99.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
$5,290.00
Market Cap Chart
Since May 30, 2013, Access Bio's market cap has decreased from 269.10B to 185.01B, a decrease of -31.25%. That is a compound annual growth rate of -3.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 185.01B | 1.35% |
| Dec 30, 2024 | 182.55B | -39.72% |
| Dec 28, 2023 | 302.84B | -26.91% |
| Dec 29, 2022 | 414.36B | -27.26% |
| Dec 30, 2021 | 569.63B | -27.38% |
| Dec 30, 2020 | 784.36B | 1,061.10% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.52T |
| Celltrion | 38.80T |
| ALTEOGEN | 23.35T |
| Yuhan | 8,487.38B |
| Peptron | 8,235.61B |
| SK Biopharmaceuticals | 7,878.31B |
| PharmaResearch | 6,909.12B |
| LigaChem Biosciences | 5,666.20B |